Inventor
JIANG LAN
US78 patents
⚠️ This page may combine multiple inventors who share the name “JIANG LAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
THERAVANCE INC
12 patentsUS7622508B2Nov 24, 2009
8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
THERAVANCE INC39 citations94
US8377964B2Feb 19, 2013
Benzimidazole-carboxamide compounds as 5-HT4 receptor agonists
THERAVANCE INC10 citations93
US7759363B2Jul 20, 2010
Benzimidazole-carboxamide compounds as 5-HT4, receptor agonists
THERAVANCE INC18 citations93
US7902220B2Mar 8, 2011
8-azabicyclo[3.2.1]octyl-2-hydroxybenzamide compounds as mu opioid receptor antagonists
THERAVANCE INC14 citations92
US7399862B2Jul 15, 2008
5-HT4 receptor agonist compounds
THERAVANCE INC26 citations92
US7396933B2Jul 8, 2008
Quinolinone-carboxamide compounds
THERAVANCE INC28 citations92
US7691878B2Apr 6, 2010
Heteroarylalkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
THERAVANCE INC13 citations84
US7534889B2May 19, 2009
5-HT4 receptor agonist compounds
THERAVANCE INC13 citations84
US7498442B2Mar 3, 2009
Quinolinone-carboxamide compounds
THERAVANCE INC10 citations84
US7446114B2Nov 4, 2008
Quinolinone compounds as 5-HT4 receptor agonists
THERAVANCE INC10 citations84
US7902221B2Mar 8, 2011
Amidoalkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
THERAVANCE INC10 citations82
US7875629B2Jan 25, 2011
Quinolinone compounds as 5-HT4 receptor agonists
THERAVANCE INC6 citations74
GILEAD SCIENCES INC
12 patentsUS11084832B2Aug 10, 2021
Bridged tricyclic carbamoylpyridone compounds and their pharmaceutical use
GILEAD SCIENCES INC25 citations93
US10703733B2Jul 7, 2020
MCL-1 inhibitors
GILEAD SCIENCES INC12 citations93
US11897892B2Feb 13, 2024
Substituted pyridotriazine compounds and uses thereof
GILEAD SCIENCES INC6 citations85
US10988451B2Apr 27, 2021
MCL-1 inhibitors
GILEAD SCIENCES INC10 citations85
US12024528B2Jul 2, 2024
Bridged tricyclic carbamoylpyridone compounds and uses thereof
GILEAD SCIENCES INC6 citations84
US11697652B2Jul 11, 2023
Tetracyclic compounds and uses thereof
GILEAD SCIENCES INC7 citations84
US11613546B2Mar 28, 2023
Substituted pyridotriazine compounds and uses thereof
GILEAD SCIENCES INC9 citations84
US11548902B1Jan 10, 2023
Bridged tricyclic carbamoylpyridone compounds and their pharmaceutical use
GILEAD SCIENCES INC7 citations84
US12187734B2Jan 7, 2025
Substituted pyridotriazine compounds and uses thereof
GILEAD SCIENCES INC1 citations74
US11643400B2May 9, 2023
MCL-1 inhibitors
GILEAD SCIENCES INC4 citations74
US12054496B2Aug 6, 2024
Bridged tricyclic carbamoylpyridone compounds and uses thereof
GILEAD SCIENCES INC2 citations72
US11667652B2Jun 6, 2023
MCL1 inhibitors
GILEAD SCIENCES INC2 citations72
THERAVANCE BIOPHARMA R&D IP LLC
9 patentsUS10526330B2Jan 7, 2020
JAK kinase inhibitor compounds for treatment of respiratory disease
THERAVANCE BIOPHARMA R&D IP LLC15 citations94
US10493077B2Dec 3, 2019
Fused imidazo-piperidine JAK inhibitor compound
THERAVANCE BIOPHARMA R&D IP LLC14 citations94
US10100049B2Oct 16, 2018
JAK kinase inhibitor compounds for treatment of respiratory disease
THERAVANCE BIOPHARMA R&D IP LLC28 citations93
US10377751B2Aug 13, 2019
8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
THERAVANCE BIOPHARMA R&D IP LLC3 citations84
US10081626B2Sep 25, 2018
8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
THERAVANCE BIOPHARMA R&D IP LLC5 citations84
US11548887B2Jan 10, 2023
8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
THERAVANCE BIOPHARMA R&D IP LLC1 citations73
US11299492B2Apr 12, 2022
JAK kinase inhibitor compounds for treatment of respiratory disease
THERAVANCE BIOPHARMA R&D IP LLC2 citations73
US11160810B2Nov 2, 2021
Fused imidazo-piperidine JAK inhibitor compound
THERAVANCE BIOPHARMA R&D IP LLC2 citations73
US10745394B2Aug 18, 2020
8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
THERAVANCE BIOPHARMA R&D IP LLC2 citations72
PLIANT THERAPEUTICS INC
6 patentsUS10793564B2Oct 6, 2020
Amino acid compounds and methods of use
PLIANT THERAPEUTICS INC25 citations93
US10696672B2Jun 30, 2020
Amino acid compounds and methods of use
PLIANT THERAPEUTICS INC21 citations93
US10604520B2Mar 31, 2020
N-acyl amino acid compounds and methods of use
PLIANT THERAPEUTICS INC20 citations93
US11634418B2Apr 25, 2023
Amino acid compounds and methods of use
PLIANT THERAPEUTICS INC5 citations85
US11560376B2Jan 24, 2023
Amino acid compounds and methods of use
PLIANT THERAPEUTICS INC6 citations83
US11673887B2Jun 13, 2023
N-acyl amino acid compounds and methods of use
PLIANT THERAPEUTICS INC3 citations72
LONG DANIEL D
6 patentsUS9663509B2May 30, 2017
8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
LONG DANIEL D10 citations92
US9206172B2Dec 8, 2015
8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
LONG DANIEL D10 citations92
US8927573B2Jan 6, 2015
8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
LONG DANIEL D10 citations92
US8664242B2Mar 4, 2014
8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
LONG DANIEL D13 citations92
US8263618B2Sep 11, 2012
8-azabicyclo[3.2.1]octane compounds as MU opioid receptor antagonists
LONG DANIEL D18 citations92
US8518966B2Aug 27, 2013
Amidoalkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
LONG DANIEL D6 citations83
MCKINNELL ROBERT MURRAY
2 patentsSAITO DAISUKE ROLAND
1 patentTRAPP SEAN G
1 patentBEIJING INSTITUTE TECH
1 patentShowing the top 50 of 78 patents by PatentIndex Score.